KNSA
Kiniksa Pharmaceuticals Ltd
NASDAQ: KNSA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.99
-1.60% today
Updated 2026-04-29
Market cap
$4.08B
P/E ratio
58.23
P/S ratio
6.02x
EPS (TTM)
$0.91
Dividend yield
—
52W range
$25 – $54
Volume
0.8M
Kiniksa Pharmaceuticals Ltd (KNSA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.87M | $-50.22M | $-81.01M | $-158.37M | $-136.53M | $-126.30M | $5.81M | $13.30M | $25.69M | $25.69M |
| Capital expenditures | $3000.00 | $69000.00 | $5.29M | $3.20M | $283000.00 | $20.41M | $105000.00 | $130000.00 | $277000.00 | $277000.00 |
| Depreciation | $22000.00 | $28000.00 | $286000.00 | $2.07M | $2.40M | $2.35M | $2.40M | $2.34M | $1.70M | — |
| Stock-based comp | $368000.00 | $897000.00 | $5.70M | $15.08M | $20.88M | $25.17M | $25.12M | $27.15M | $30.69M | $30.69M |
| Free cash flow | $-21.87M | $-50.29M | $-86.30M | $-161.57M | $-136.81M | $-146.71M | $5.70M | $13.17M | $25.41M | $25.41M |
| Investing cash flow | $-3000.00 | $-69000.00 | $-239.20M | $49.21M | $-23.44M | $128.63M | $-8.08M | $-29.56M | $37.67M | — |
| Financing cash flow | $42.51M | $39.87M | $346.74M | $84.11M | $227.09M | $5.88M | $2.52M | $1.50M | $12.27M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $26.53M | $-25.05M | $67.11M | $8.22M | $245000.00 | — | — | — |